Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer
Clinical trial NCT06008925 · UNKNOWN
Trial details
- NCT number
- NCT06008925
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-17
- Primary completion
- 2025-12-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.